Literature DB >> 21292898

Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.

Agnès Le Port1, Gilles Cottrell, Célia Dechavanne, Valérie Briand, Aziz Bouraima, José Guerra, Isabelle Choudat, Achille Massougbodji, Benjamin Fayomi, Florence Migot-Nabias, André Garcia, Michel Cot.   

Abstract

The efficiency of malaria prevention during pregnancy was compared between three studies in Benin for malaria infection of the placenta (MIP) and low birth weight (LBW). The first was carried out when chloroquine prophylaxis was still recommended, the second was an intermittent preventive treatment in pregnancy (IPTp) clinical trial comparing sulfadoxine pyrimetamine (SP) versus mefloquine, and the third was an observational study after SP-IPTp national implementation. We showed an association between the use of IPTp and the reduction of LBW (10% with national IPTp and 8.7% in IPTp trial versus 15.7% in pre-trial study). The effect on MIP was better in the trial (2.9% versus 11.2% and 16.7% for national IPTp and pre-trial studies, respectively). In spite of a good overall compliance with the national IPTp (with 84% of women taking at least one dose of SP), there are still failures in adherence to the directly observed therapy (DOT) scheme and needs for better training of health staff.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292898      PMCID: PMC3029181          DOI: 10.4269/ajtmh.2011.10-0319

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

Review 1.  From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.

Authors:  Jane Crawley; Jenny Hill; Juliana Yartey; Magda Robalo; Antoine Serufilira; Antoinette Ba-Nguz; Elaine Roman; Ayo Palmer; Kwame Asamoa; Richard Steketee
Journal:  Lancet Infect Dis       Date:  2007-02       Impact factor: 25.071

2.  Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges.

Authors:  Jenny Hill; Peter Kazembe
Journal:  Trop Med Int Health       Date:  2006-04       Impact factor: 2.622

3.  Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.

Authors:  Sodiomon B Sirima; Annett H Cotte; Amadou Konaté; Allisyn C Moran; Kwame Asamoa; Edith C Bougouma; Amidou Diarra; Alphonse Ouédraogo; Monica E Parise; Robert D Newman
Journal:  Am J Trop Med Hyg       Date:  2006-08       Impact factor: 2.345

Review 4.  The burden of malaria in pregnancy in malaria-endemic areas.

Authors:  R W Steketee; B L Nahlen; M E Parise; C Menendez
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

5.  The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi.

Authors:  R W Steketee; J J Wirima; A W Hightower; L Slutsker; D L Heymann; J G Breman
Journal:  Am J Trop Med Hyg       Date:  1996       Impact factor: 2.345

Review 6.  Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.

Authors:  Feiko O ter Kuile; Annemieke M van Eijk; Scott J Filler
Journal:  JAMA       Date:  2007-06-20       Impact factor: 56.272

7.  Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon.

Authors:  Michael Ramharter; Katharina Schuster; Marielle K Bouyou-Akotet; Ayola A Adegnika; Kristen Schmits; Ghyslain Mombo-Ngoma; Selidji T Agnandji; Johannes Nemeth; Solange Nzenze Afène; Saadou Issifou; Isabelle Ndombi Onnas; Maryvonne Kombila; Peter G Kremsner
Journal:  Am J Trop Med Hyg       Date:  2007-09       Impact factor: 2.345

8.  Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin.

Authors:  Agnès Aubouy; Nadine Fievet; Gwladys Bertin; Jean C Sagbo; Hortense Kossou; Dorothée Kinde-Gazard; Richard Kiniffo; Achille Massougbodji; Philippe Deloron
Journal:  Trop Med Int Health       Date:  2007-07       Impact factor: 2.622

9.  Women's experiences and views about costs of seeking malaria chemoprevention and other antenatal services: a qualitative study from two districts in rural Tanzania.

Authors:  Godfrey M Mubyazi; Paul Bloch; Pascal Magnussen; Øystein E Olsen; Jens Byskov; Kristian S Hansen; Ib C Bygbjerg
Journal:  Malar J       Date:  2010-02-17       Impact factor: 2.979

10.  Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin.

Authors:  Lise Denoeud; Nadine Fievet; Agnès Aubouy; Paul Ayemonna; Richard Kiniffo; Achille Massougbodji; Michel Cot
Journal:  Malar J       Date:  2007-03-06       Impact factor: 2.979

View more
  13 in total

1.  The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates.

Authors:  Sébastien Briolant; Hervé Bogreau; Marine Gil; Housem Bouchiba; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

2.  Prevention and control of malaria and sleeping sickness in Africa: where are we and where are we going?

Authors:  Vincent Corbel; Marie-Claire Henry
Journal:  Parasit Vectors       Date:  2011-03-16       Impact factor: 3.876

3.  Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.

Authors:  Gwladys Bertin; Valérie Briand; Diana Bonaventure; Ambre Carrieu; Achille Massougbodji; Michel Cot; Philippe Deloron
Journal:  Malar J       Date:  2011-07-19       Impact factor: 2.979

4.  Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d'Ivoire.

Authors:  A Toure Offianan; Louis K Penali; Ma Coulibaly; Nl Tiacoh; Aab Ako; Eg Adji; B Coulibaly; D Koffi; D Sarr; R Jambou; M Kone
Journal:  Infect Drug Resist       Date:  2012-03-12       Impact factor: 4.003

5.  Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration.

Authors:  Bich-Tram Huynh; Nadine Fievet; Valérie Briand; Sophie Borgella; Achille Massougbodji; Philippe Deloron; Michel Cot
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

Review 6.  Mefloquine for preventing malaria during travel to endemic areas.

Authors:  Maya Tickell-Painter; Nicola Maayan; Rachel Saunders; Cheryl Pace; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

7.  Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria.

Authors:  Olorunfemi E Amoran; Adebayo A Ariba; Christy A Iyaniwura
Journal:  Reprod Health       Date:  2012-08-13       Impact factor: 3.223

8.  Statistical properties of parasite density estimators in malaria.

Authors:  Imen Hammami; Grégory Nuel; André Garcia
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

9.  Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA).

Authors:  Alexandre Manirakiza; Abdoulaye Sepou; Eugène Serdouma; Samuel Gondje; Ghislain Géraud Banthas Bata; Sandrine Moussa; Aude Boulay; Jean Methode Moyen; Olga Sakanga; Lenaig Le-Fouler; Mirdad Kazanji; Muriel Vray
Journal:  Trials       Date:  2013-08-14       Impact factor: 2.279

10.  Plasmodium falciparum parasitaemia among booked parturients who received two doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment in pregnancy (IPTp) in a tertiary health facility Southeast Nigeria.

Authors:  Matthew Igwe Nwali; Brown N Ejikeme; Joseph J Agboeze; Azubike K Onyebuchi; Bonaventure O Anozie
Journal:  Niger Med J       Date:  2015 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.